Clinical trials

  • DETALIMOGENE VORAPLASMID for Non-muscle invasive bladder cancer (NMIBC)
  • PACLITAXEL for Metastatic pancreatic cancer | Pancreatic adenocarcinoma
  • IANALUMAB for Primary immune thrombocytopenia
  • IMATINIB MESILATE for Chronic myeloid leukaemia
  • Rilpivirine for HIV-1 infection
  • Hydrocortisone for Primary adrenal insufficiency
  • Rivaroxaban (with lactose monohydrate excipient listed) for Intracardiac thrombus
  • Trametinib for Metastatic malignancy | BRAF gene mutation (impaired kinase activity)
  • MITOMYCIN for Non-muscle invasive bladder cancer
  • PERTUZUMAB for Breast cancer | Early HER2-positive breast cancer
  • durvalumab for Non-small cell lung cancer (stage I/II) | EGFR-mutant non-small cell lung cancer
  • RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E for Psoriasis vulgaris | Psoriatic arthritis